all report title image

GLOBAL BIO-IMAGING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Bio-imaging Market, By Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Position Emission Tomography (PET), Ultrasound , X-ray, Others), By End User (Hospitals & diagnostic centers, Academic & research institutes, Pharmaceutical & biotech companies, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : Jan 2024
  • Code : CMI6581
  • Pages :172
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Challenges And Opportunities

Global Bio-imaging Market- Drivers

  • Technological advancements in bio-imaging modalities: Technological advancements in bio-imaging modalities are strongly driving the growth of global bio-imaging market. The new generation bio-imaging techniques are allowing researchers to gain deeper insights into biological processes at the cellular and molecular level. Advanced modalities like optogenetics, two-photon microscopy and super resolution microscopy are enabling researchers to visualize cellular structures and interactions like never before. These high-resolution live cell imaging techniques are revolutionizing the fields of neuroscience and developmental biology by providing incredibly detailed real-time views of complex biological systems.
  • Growing prevalence of chronic and infectious diseases: Growing burden of chronic and infectious diseases across the globe is a major factor driving the growth of the global bio-imaging market. With rising life expectancy and changing lifestyle trends, non-communicable diseases like cancer, cardiovascular diseases, and neurological disorders are on the rise. For instance, according to the American Cancer Society’s report, in January 2022, there will be an estimated 1.9 Bn new cancer cases diagnosed and 609,360 cancer deaths in the U.S.
  • Growing applications of bio-imaging in drug discovery, clinical trials and regenerative medicine research: Bio-imaging is playing a pivotal role in various fields of medical research and drug development. With advancements in high-resolution imaging techniques such as MRI, PET, CT and multi-photon microscopy, researchers are able to gain deeper insights into biological processes at the molecule, cell and whole organ levels. This is driving significant growth in the bio-imaging market. Technology providers are increasingly offering advanced bio-imaging solutions integrated with data analysis and artificial intelligence capabilities. This is enabling researchers to longitudinal track disease progression and drug response non-invasively over time at high spatiotemporal resolution.

Global Bio-imaging Market- Opportunities

  • Companion diagnostics and personalized medicine: Companion diagnostics along with personalized medicine offers a great opportunity to drive growth in the global bio-imaging market. With advancements in precision medicine and targeted drug therapies, the need for biomarkers and companion diagnostics is increasing significantly. Bio imaging techniques play a vital role in disease diagnosis, treatment selection, and monitoring drug response at an individual level. These personalized healthcare approaches require robust bio-imaging tools that can accurately detect molecular and cellular abnormalities.
  • Hybrid imaging systems: Hybrid imaging systems have the potential to be a major opportunity in the global bio-imaging market. Hybrid imaging combines two or more imaging modalities together, harnessing the strengths of each individual technique while compensating for their limitations. This integrated approach allows researchers and medical professionals to gain complimentary anatomical and functional insights from a single examination. Hybrid imaging is gaining traction as it provides more comprehensive visualization and characterization of biological systems. Combining modalities such as PET/CT, SPECT/MRI and ultrasound with CT or MRI gives clinicians and scientists enhanced functionality.
  • High capital investment requirements: One of the key factors that are restraining the growth of the global bio-imaging market is the high capital investment requirements for various imaging modalities and infrastructure development. Establishing a state-of-the-art molecular or functional imaging facility involves significant investments in advanced medical imaging equipment like PET/CT, MRI, ultrasound, and others. These high-end systems come with a steep price tag of millions of dollars. Moreover, to get the most out of these systems, regular software and hardware upgrades are needed which leads to additional recurring costs. The expensive nature of bio-imaging technologies poses a major barrier for research institutions and hospitals especially in developing regions to adopt advanced imaging technologies at a large scale.
  • Shortage of skilled professionals: The shortage of skilled professionals is significantly hampering the growth of the global bio-imaging market. As bio-imaging techniques continue to advance at a rapid pace with innovations like artificial intelligence integration and nanotechnology, there is a growing need for trained medical imaging technicians, radiologists, and other specialized healthcare professionals who can efficiently operate sophisticated imaging equipment and accurately analyze the scans. However, most countries are facing an acute deficit of such skilled human resources.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.